Cargando…
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
Drug delivery into the central nervous system (CNS) is challenging due to the blood–brain barrier (BBB) and drug delivery into the brain overcoming the BBB can be achieved using nanoparticles such as dendrimers. The conventional cationic dendrimers used are highly toxic. Therefore, the present study...
Autores principales: | Srinageshwar, Bhairavi, Peruzzaro, Sarah, Andrews, Melissa, Johnson, Kayla, Hietpas, Allison, Clark, Brittany, McGuire, Crystal, Petersen, Eric, Kippe, Jordyn, Stewart, Andrew, Lossia, Olivia, Al-Gharaibeh, Abeer, Antcliff, Aaron, Culver, Rebecca, Swanson, Douglas, Dunbar, Gary, Sharma, Ajit, Rossignol, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372641/ https://www.ncbi.nlm.nih.gov/pubmed/28335421 http://dx.doi.org/10.3390/ijms18030628 |
Ejemplares similares
-
A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimers
por: Munro, Nikolas, et al.
Publicado: (2019) -
A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020) -
PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
por: Fana, Michael, et al.
Publicado: (2020) -
Use of Polyamidoamine Dendrimers in Brain Diseases
por: Florendo, Maria, et al.
Publicado: (2018) -
Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines
por: Gallien, John, et al.
Publicado: (2021)